Tesamorelin is a synthetic GHRH analog used in lab studies of GH-axis signaling, metabolic and endocrine models, and physiologic GH secretion patterns in controlled research settings.
$45.00 – $75.00Price range: $45.00 through $75.00
2 Vials
5% Off
3 Vials
8% Off
5 Vials
12% Off
Verified purity data and more—third party tested by Freedom Diagnostics.
Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) studied in laboratory research for its interaction with the growth-hormone / IGF-1 axis and pituitary signaling pathways. As a GHRH-analog model compound, it is investigated in endocrine, metabolic, and longevity research only — not for human or therapeutic use.
In experimental models, Tesamorelin is studied for its role in endogenous growth-hormone signaling pathways and physiologic GH-release patterns, in contrast to direct hormone administration.
Preclinical and analytical investigations have explored Tesamorelin in models studying:
• GHRH-receptor signaling pathways
• growth-hormone / IGF-1 axis regulation
• lipid- and glucose-metabolism signaling models
• body-composition research models
• endocrine and metabolic pathway studies
Compound Name: Tesamorelin
Peptide Class: GHRH Analog (Growth Hormone-Releasing Hormone analog)
Appearance: Lyophilized white powder
Purity: ≥99% (HPLC tested)
Testing Methods: HPLC & Mass Spectrometry
Vial Size: 3 ml
Storage: Store dry at 2–8 °C. After reconstitution, refrigerate.
Each batch undergoes analytical verification to confirm peptide identity, purity, and net peptide content.
• Third-party tested for purity, identity, and net peptide content
• Batch-specific Certificate of Analysis (HPLC & Mass Spectrometry)
• Fast, secure U.S. shipping
Explore the science: Tesamorelin research overview and growth-hormone peptides research.
This compound is supplied strictly for laboratory research purposes only.
Not intended for human consumption, therapeutic use, or veterinary use.
Explore additional research peptides that may complement your current areas of study.



